Skip to main content

Table 2 Summary of the prevalence of hepatitis B according to selected studies and biomarkers

From: Epidemiology of viral hepatitis in the Republic of Congo: review

Study

Sample size

HBsAg prevalence, n (%)*

Anti-HBe prevalence, n (%)µ

Anti-HBc prevalence, n (%)#

Atipo-Ibarra et al. [22] (1)

1363

9.9

  

Angounda et al. [43] (2)

648

6.6

8.2

62.7

Makuwa et al. [83] (3)

334

8.5

4.2

93.6

  1. p value: p (1) → (2) < 0.0192; p (1) → (3) < 0.5*; p (2) → (3) < 0.026µ; p (2) → (3) < 0.00000#; p (2) → (3) < 0.29*
Back to article page

BMC Research Notes

ISSN: 1756-0500

Contact us